DR info

Clinical trials : 6 / Drugs : 6 - (DrugBank : 4) / Drug target genes : 9 - Drug target pathways : 14

Menkes disease and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
169	Menkes disease	-
170	Occipital horn syndrome	9.000
6	Parkinson disease	9.000
17	Multiple system atrophy	9.000
46	Malignant rheumatoid arthritis	9.000
96	Crohn disease	9.000
5	Progressive supranuclear palsy	9.000
11	Myasthenia gravis	9.000
22	Moyamoya disease	9.000
70	Spinal stenosis	9.000
113	Muscular dystrophy	7.232
118	Myelomeningocele	6.806
2	Amyotrophic lateral sclerosis	5.508
280	Huge arteriovenous malformation with cervicofacial or limb lesion	4.857
215	Tetralogy of Fallot	4.667
288	Autoimmune acquired coagulation factor deficiency	4.667
206	Fragile X syndrome	4.222
8	Huntington disease	4.143
13	Multiple sclerosis/Neuromyelitis optica	4.045
57	Idiopathic dilated cardiomyopathy	4.012
210	Single Ventricle	3.125
323	Aromatic L-amino acid decarboxylase deficiency	3.000
226	Interstitial cystitis with Hunners ulcer	2.951
85	Idiopathic interstitial pneumonia	2.890
86	Pulmonary arterial hypertension	2.889
278	Huge lymphatic malformation with cervicofacial lesion	2.200
67	Polycystic kidney disease	2.012
127	Frontotemporal lobar degeneration	2.000
58	Hypertrophic cardiomyopathy	1.963
28	Systemic amyloidosis	1.912
212	Tricuspid atresia	1.750
167	Marfan syndrome	1.600
4	Primary lateral sclerosis	1.316
254	Porphyria	1.316
227	Osler disease	1.261
158	Tuberous sclerosis	1.171
78	Hypopituitarism	1.136
296	Biliary atresia	1.133
21	Mitochondrial disease	1.128
90	Retinitis pigmentosa	1.122
107	Juvenile idiopathic arthritis	1.115
34	Neurofibromatosis	1.069
65	Primary immunodeficiency	1.067
157	Sturge-Weber syndrome	1.067
111	Congenital myopathy	1.000